Status of the progeny of rats treated with platinum-containing cytostatics

By Borovskaya T.   Gol’dberg V.   Poluektova M.   Pakhomova A.   Timina E.   Gol’dberg E.  

Bulletin of Experimental Biology and Medicine, Vol. 138, Iss. 3, 2004-09 ,pp. : 267-270

Springer Publishing Company

Access to resources Recommend Favorite

The effect of the catalytic topoisomerase II inhibitor dexrazoxane (ICRF-187) on CC9C10 hybridoma viability and productivity

By Barnabé Norman   Butler Michael   Hasinoff Brian  

Cytotechnology, Vol. 37, Iss. 2, 2001-10 ,pp. : 107-117

Springer Publishing Company

Access to resources Recommend Favorite

Effect of the DNA topoisomerase II inhibitor VP-16 on illegitimate recombination in yeast chromosomes

By Asami Y.   Jia D.-W.   Tatebayashi K.   Yamagata K.   Tanokura M.   Ikeda H.  

Gene, Vol. 291, Iss. 1, 2002-05 ,pp. : 251-257

Elsevier

Access to resources Recommend Favorite

Dissociation of CDK2 from Cyclin A in Response to the Topoisomerase II Inhibitor Etoposide in v-src-Transformed but Not Normal NIH 3T3 Cells

By Chen G.   Hitomi M.  

Experimental Cell Research, Vol. 249, Iss. 2, 1999-06 ,pp. : 327-336

Elsevier

Access to resources Recommend Favorite

N-nitrosomethylurea-induce carcinogenesis in the progeny of male rats of different ages

By Anisimov V.N.   Gvardina O.E.  

Mutation Research DNAging, Vol. 316, Iss. 3, 1995-02 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite